Nitin Khanna has spent several decades in the investment world, with much of this being at the helm of his own companies. Throughout this time, his investment portfolio has included quite a significant number of industries, with this diverse range helping him to minimize the risk involved in his investments. However, Nitin Khanna was first involved in the technology industry, with his first company, Saber Corp, achieving a considerable amount of success in the niche. The Portland-based Saber Corp was founded in 1997 and quickly grew to be the largest IT solutions company serving state governments.
After a few years with Saber Corp, Nitin Khanna sold the technology firm to industry giant EDS before working with the larger business for a few years afterward. However, Khanna soon left the company to continue on his own path, which led to him founding MergerTech, a technology-focused investment and financial advice company that began to expand relatively quickly. As CEO of the firm, Khanna led the majority of the company’s more prominent negotiations and strategies, which subsequently led to success and continued expansion. Aside from MergerTech, Khanna has been involved with a few other companies in recent years.
One prominent example was Cura Cannabis Solutions, which he founded in 2015 to capitalize on the relatively young cannabis market in the United States, which has been growing considerably in recent years. Nitin Khanna has also been involved with philanthropic causes, such as the Portland Children’s Museum and the Urban League of Portland, where he served as a board member.
Though the companies that Nitin Khanna has been involved in have been spread across a broad range of industries, his leadership with them has had a few things in common. One of the most significant of these is the fact that he’s always been execution-focused. Khanna has highlighted the fact that having an idea for a business can be relatively easy; acting on and executing the idea successfully is what takes work, and is one of the more notable aspects of what differentiates winners and losers in an industry. This is especially true given the fact that there can be hundreds of potential competitors at any given time.
Pelvic floor disorders are one of the most dangerous reproduction disorders if left untreated. Marc Beer is, however, one of the few professionals that are rewriting this reality by investing and in alternative ways to treat reproduction disorders. Late last year, Beer was able to raise more money for this important cause. He was able to raise 10 million dollars as a venture debt and an addition of 32 million dollars.
According to Renovia management, the funding was timely, and it will help the company to design and produce futuristic medication for people suffering from all types of pelvic floor disorders. However, this will not be the first product by this company, but it will be a perfect continuation of the company’s tradition in making the best products.
Investors in the medical world believe in consistency, which Mark Beer has shown through this company. Early last year, Renovia was one of the few companies that the FDA approved their products. According to the management of this company, Leva was their first major product and approval by FDA is a perfect illustration that the company is not only innovative but it also operates under the relevant medical rules.
This approval was one of the reasons why investors trusted Marc Beer’s dream. According to Beer, the project aims at helping over 250 million women who have different complications (pelvic disorders) around the world.
Another angle investors use to evaluate such a major project is ‘if the company has the capacity’. Renovia is a hub for the best innovators and researchers in the world of medicine. Marc Beer believes that having the best human resource, especially in the form of researchers is key in being a competitive company.
In the past 24 months, Beer has brought Samantha Pulliam to the team as well as José Bohorquez, PhD. The two are experts in their respective fields and apart from being highly educated; they have been in this market niche for years. The collection of these professionals was enough evidence that Renovia has the capacity and the necessary resources to provide medication to the 250 million women.
However, the biggest reason why investors were willing to put their resources on this project was Marc Beer’s resume. In the last two and a half decades, he has revolutionized both the biotechnology and pharmaceutical world through his innovative projects. Beer is one of the few investors in the medical world that have worked for different companies under different capacities.
Working for different companies has given him unmatched experience. However, Beer believes that his redefining moment in his career is when he joined hands with the talented Yolanda Lorié and the visionary Ramon Iglesias to create this entity. In this entity, he is not only the CEO and the chair but also a mentor to young professionals in Renovia.
When you successfully raise money to support the activities of your startup company, it always is a significant achievement. That is what Marc Beer, CEO of Renovia Inc. did. He recently announced that the company had secured a deal worth $32 million in support of the development of products that will help in the treatment of pelvic floor disorders. The money, raised through Series B round will be used by the company to develop diagnostics and therapeutic equipment for Leva, Renovia’s first product. Leva received the FDA approval in April and have been on a mission to create innovative gear that will help women suffering from these conditions.
Pelvic floor disorders
One of the many pelvic floor disorders that the company wants to treat with the new equipment is urinary incontinence. According to various studies, this disease affects more than 250 million from around the world. The worst part is that most of these women do not have access to treatment because the equipment has not been developed yet. Therefore, they suffer hoping that things will change one day. It is good news to these women because Marc Beer has now secured the funding that his company needed to come up with appropriate diagnostic equipment. There are also planning to create a newer version of Leva.
Thrilled to get support
While announcing the news, CEO Marc Beer said that he was excited to gain support for leading health care investors and that the company will ensure that they have machines and other re-equipment that will make it easy to diagnose, treat, and improve the lives patients suffering from pelvic floor disorders. He went ahead to add that since the companies have similar visions to theirs, they expected to have a smooth working relationship, and this should speed up the process of finding the right solutions to the problems that affect hundreds of millions of women.
Although the company declined to respond to questions about the investment and the products that are still in the pipelines, Marc Beer indicated that they would like to combine their innovative sensor technologies with unique proprietary skills to realize their goals. The digital health platform is still top on their priority list so that they can provide better information to patients. Customers will now know what to expect once they start treatment thanks to the availability of more information.
About Marc Beer
Marc Beer is not a new name to the healthcare industry. He has helped to formulate solutions that have improved the quality of health services. He is currently the CEO of Renovia Inc., a company that is based in Boston and which specializes in the development of equipment that helps in the treatment of pelvic floor disorders such as urinary incontinence. Learn more: https://www.slideshare.net/MarcBeer
Renovia Inc.is a biotechnology firm that is headed by Marc Beer. He is the chief executive of the corporation. Over the years, Marc Beer has gained popularity for his ability to transform numerous start-up companies into commercial entities that eventually gain the financial strength to attain their goals. As the founder of Renovia Inc., Marc Beer sought some funding worth $42 million. The money would then be used to finance the endeavors of the biotechnology company. The funds were acquired through venture debt and Series B funding.
At the moment, Renovia Inc. is trying to come up with a suitable form of treatment for the pelvic floor disorder. The company has been working towards developing advanced types of technology that can be used to diagnose and test ailments such as urinary continence. The pelvic floor disorder and the urinary continence are somewhat related disorders. The ailment has affected approximately $42 million women worldwide. The $42 million will also be used to come up with affordable drugs that will be used in the treatment of the pelvic floor disorder in women.
Some companies such as the Longwood Fund believe in the research being carried out by Renovia Inc., which is why they attended the fundraisers and issued a reasonable amount of money to support the company’s cause. Other companies such as Perceptive Advisers were tasked with offering some advice to Renovia Inc. Since the Renovia Inc., has access to a considerable amount of funds, the corporation can further their research on formulating a drug that can be used to treat the pelvic floor disorder. Renovia Inc. has successfully developed a digitized health system known as Leva. The Leva technology also has been approved by the FDA. The Renovia Inc. will channel some part of the funds to come up with a more advanced form of the Leva technology. Marc Beer is hopeful that the Renovia Inc., will come up with a solution to the urinary continence and the pelvic floor disorder. Learn more: https://renoviainc.com/leadership/
Marc Beer has been transforming start-up companies into profitable commercial entities for more than 25 years. He has garnered lots of experience about the pharmaceutical industry, business, and development throughout the two and a half decades. His skill set as a business person and a remarkable leader can be witnessed through Renovia Inc. Marc Beer founded the company in 2016, and the corporation has achieved numerous milestones in the healthcare sector. Marc Beer is passionate about the goals that the Renovia Inc., is set to achieve. He also ensured that the fundraiser went on accordingly thus ensuring that the company had the necessary funds to fuel some of the projects such as finding a suitable remedy for the pelvic floor disorder